Gene, Cell and Tissue

Published by: Kowsar

Association Study of TPH1 (rs1800532) and TPH2 (rs4570625) Polymorphisms in Type 1 Bipolar Disorder in Iran

Mohammad Hormozi 1 , Fateme Zarei 1 , Ava Rasouli 2 , Saeedeh Salimi 3 , Omid Taji 4 and Mehrnaz Narooie-Nejad 5 , *
Authors Information
1 Department of Psychiatry, Bahran Psychiatry Teaching Hospital, Zahedan University of Medical Sciences, Zahedan, Iran
2 Department of Laboratory Science, Paramedical School, Zahedan University of Medical Sciences, Zahedan, Iran
3 Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
4 Department of Biology, Sistan and Baluchestan University, Zahedan, Iran
5 Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Gene, Cell and Tissue: October 31, 2018, 5 (4); e86109
  • Published Online: January 12, 2019
  • Article Type: Research Article
  • Received: November 5, 2018
  • Revised: December 31, 2018
  • Accepted: January 5, 2019
  • DOI: 10.5812/gct.86109

To Cite: Hormozi M, Zarei F, Rasouli A, Salimi S, Taji O, et al. Association Study of TPH1 (rs1800532) and TPH2 (rs4570625) Polymorphisms in Type 1 Bipolar Disorder in Iran, Gene Cell Tissue. 2018 ; 5(4):e86109. doi: 10.5812/gct.86109.

Copyright © 2019, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Goodwin FK, Jamison KR. Manic-depressive illness: Bipolar disorders and recurrent depression. 1. Oxford University Press; 2007.
  • 2. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558-69. doi: 10.1038/ [PubMed: 18317468]. [PubMed Central: PMC3777816].
  • 3. Bauer M, Pfennig A. Epidemiology of bipolar disorders. Epilepsia. 2005;46 Suppl 4:8-13. [PubMed: 15968806].
  • 4. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276(4):293-9. [PubMed: 8656541].
  • 5. Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R, et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A. 2009;106(18):7501-6. doi: 10.1073/pnas.0813386106. [PubMed: 19416921]. [PubMed Central: PMC2678639].
  • 6. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-3. doi: 10.1038/3218. [PubMed: 9809543].
  • 7. Vieta E, Benabarre A, Colom F, Gasto C, Nieto E, Otero A, et al. Suicidal behavior in bipolar I and bipolar II disorder. J Nerv Ment Dis. 1997;185(6):407-9. [PubMed: 9205428].
  • 8. Tsai SY, Kuo CJ, Chen CC, Lee HC. Risk factors for completed suicide in bipolar disorder. J Clin Psychiatry. 2002;63(6):469-76. [PubMed: 12088157].
  • 9. Havermans R, Nicolson NA, Devries MW. Daily hassles, uplifts, and time use in individuals with bipolar disorder in remission. J Nerv Ment Dis. 2007;195(9):745-51. doi: 10.1097/NMD.0b013e318142cbf0. [PubMed: 17984774].
  • 10. Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, et al. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand. 2004;110(5):383-92. doi: 10.1111/j.1600-0447.2004.00403.x. [PubMed: 15458562].
  • 11. McMorris BJ, Downs KE, Panish JM, Dirani R. Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorder. J Med Econ. 2010;13(1):23-32. doi: 10.3111/13696990903475833. [PubMed: 19961361].
  • 12. Morselli PL, Elgie R, Cesana BM. GAMIAN-Europe/BEAM survey II: Cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord. 2004;6(6):487-97. doi: 10.1111/j.1399-5618.2004.00160.x. [PubMed: 15541064].
  • 13. Altinbas K, Guloksuz S, Oral ET. Metabolic syndrome prevalence in different affective temperament profiles in bipolar-I disorder. Braz J Psychiatry. 2013;35(2):131-5. [PubMed: 23904017].
  • 14. Shabani A, Teimurinejad S, Kokar S, Ahmadzad Asl M, Shariati B, Mousavi Behbahani Z, et al. Suicide risk factors in Iranian Patients with bipolar disorder: A 21- month follow-up from BDPF study. Iran J Psychiatry Behav Sci. 2013;7(1):16-23. [PubMed: 24644495]. [PubMed Central: PMC3939979].
  • 15. Lin SK, Hung TM, Liao YT, Lee WC, Tsai SY, Chen CC, et al. Protective and risk factors for inpatient suicides: A nested case-control study. Psychiatry Res. 2014;217(1-2):54-9. doi: 10.1016/j.psychres.2014.03.008. [PubMed: 24679994].
  • 16. Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: A systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord. 2013;15(5):507-23. doi: 10.1111/bdi.12094. [PubMed: 23829436]. [PubMed Central: PMC3737391].
  • 17. Lee DH, Noh EC, Kim YC, Hwang JY, Kim SN, Jang JH, et al. Risk factors for suicidal ideation among patients with complex regional pain syndrome. Psychiatry Investig. 2014;11(1):32-8. doi: 10.4306/pi.2014.11.1.32. [PubMed: 24605121]. [PubMed Central: PMC3942549].
  • 18. Voracek M, Loibl LM. Genetics of suicide: A systematic review of twin studies. Wien Klin Wochenschr. 2007;119(15-16):463-75. doi: 10.1007/s00508-007-0823-2. [PubMed: 17721766].
  • 19. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C. 2003;123C(1):48-58. doi: 10.1002/ajmg.c.20013.
  • 20. Kennedy KP, Cullen KR, DeYoung CG, Klimes-Dougan B. The genetics of early-onset bipolar disorder: A systematic review. J Affect Disord. 2015;184:1-12. doi: 10.1016/j.jad.2015.05.017. [PubMed: 26057335]. [PubMed Central: PMC5552237].
  • 21. Talaei A, Tavakkol Afshari J, Fayyazi Bordbar MR, Pouryousof H, Faridhosseini F, Saghebi A, et al. A Study on the association of interleukin-1 cluster with genetic risk in bipolar I disorder in Iranian patients: A case-control study. Iran J Allergy Asthma Immunol. 2016;15(6):466-75. [PubMed: 28129679].
  • 22. Gonzalez-Castro TB, Juarez-Rojop I, Lopez-Narvaez ML, Tovilla-Zarate CA. Association of TPH-1 and TPH-2 gene polymorphisms with suicidal behavior: A systematic review and meta-analysis. BMC Psychiatry. 2014;14:196. doi: 10.1186/1471-244X-14-196. [PubMed: 25005534]. [PubMed Central: PMC4099217].
  • 23. Mandelli L, Mazza M, Di Nicola M, Martinotti G, Tavian D, Colombo E, et al. Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample. Clin Neuropsychiatry. 2011;8(5):295-300.
  • 24. Seifuddin F, Mahon PB, Judy J, Pirooznia M, Jancic D, Taylor J, et al. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(5):508-18. doi: 10.1002/ajmg.b.32057. [PubMed: 22573399]. [PubMed Central: PMC3582382].
  • 25. Juli G, Juli MR, Juli L. Involvement of genetic factors in bipolar disorders: Current status. Psychiatr Danub. 2012;24 Suppl 1:S112-6. [PubMed: 22945201].
  • 26. Wang CH, Liu C, Cong EZ, Xu GL, Lv TT, Zhang YL, et al. Association of tryptophan hydroxylase-2 polymorphisms with oppositional defiant disorder in a Chinese Han population. Behav Brain Funct. 2016;12(1):30. doi: 10.1186/s12993-016-0113-0. [PubMed: 27871272]. [PubMed Central: PMC5117514].
  • 27. Narooie-N. M , Moossavi M, Torkamanzehi A, Moghtaderi A. Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population. BioMed res inter. 2015;2015. doi: 10.1155/2015/427519.
  • 28. Choi KY, Yoon HK, Kim YK. Association between serotonin-related polymorphisms in 5HT2A, TPH1, TPH2 Genes and bipolar disorder in Korean population. Psychiatry Investig. 2010;7(1):60-7. doi: 10.4306/pi.2010.7.1.60. [PubMed: 20396435]. [PubMed Central: PMC2848767].
  • 29. Latsko MS, Gilman TL, Matt LM, Nylocks KM, Coifman KG, Jasnow AM. A Novel Interaction between tryptophan hydroxylase 2 (TPH2) gene polymorphism (rs4570625) and BDNF Val66Met predicts a high-risk emotional phenotype in healthy subjects. PLoS One. 2016;11(10). e0162585. doi: 10.1371/journal.pone.0162585. [PubMed: 27695066]. [PubMed Central: PMC5047464].
  • 30. Sakowski SA, Geddes TJ, Thomas DM, Levi E, Hatfield JS, Kuhn DM. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res. 2006;1085(1):11-8. doi: 10.1016/j.brainres.2006.02.047. [PubMed: 16581041].
  • 31. Wilson ST, Stanley B, Brent DA, Oquendo MA, Huang YY, Haghighi F, et al. Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood. Psychiatr Genet. 2012;22(1):15-24. doi: 10.1097/YPG.0b013e32834c0c4c. [PubMed: 21989108]. [PubMed Central: PMC3241896].
  • 32. Wong EY, Lin J, Forget BG, Bodine DM, Gallagher PG. Sequences downstream of the erythroid promoter are required for high level expression of the human alpha-spectrin gene. J Biol Chem. 2004;279(53):55024-33. doi: 10.1074/jbc.M408886200. [PubMed: 15456760].
  • 33. Grasberger H, Chang L, Shih W, Presson AP, Sayuk GS, Newberry RD, et al. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol. 2013;108(11):1766-74. doi: 10.1038/ajg.2013.304. [PubMed: 24060757]. [PubMed Central: PMC4067697].
  • 34. Li D, He L. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet. 2006;119(3):233-40. doi: 10.1007/s00439-005-0113-x. [PubMed: 16450114].
  • 35. Gizatullin R, Zaboli G, Jonsson EG, Asberg M, Leopardi R. Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry. 2006;59(4):295-300. doi: 10.1016/j.biopsych.2005.07.034. [PubMed: 16165107].
  • 36. Stefulj J, Kubat M, Balija M, Jernej B. TPH gene polymorphism and aging: Indication of combined effect on the predisposition to violent suicide. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(2):139-41. doi: 10.1002/ajmg.b.30271. [PubMed: 16389591].
  • 37. Baud P, Perroud N, Courtet P, Jaussent I, Relecom C, Jollant F, et al. Modulation of anger control in suicide attempters by TPH-1. Genes Brain Behav. 2009;8(1):97-100. doi: 10.1111/j.1601-183X.2008.00451.x. [PubMed: 19220488].
  • 38. Bellivier F, Chaste P, Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: A meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2004;124B(1):87-91. doi: 10.1002/ajmg.b.20015. [PubMed: 14681922].
  • 39. Du L, Bakish D, Hrdina PD. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. J Affect Disord. 2001;65(1):37-44. [PubMed: 11426508].
  • 40. Beden O, Senol E, Atay S, Ak H, Altintoprak AE, Kiyan GS, et al. TPH1 A218 allele is associated with suicidal behavior in Turkish population. Leg Med (Tokyo). 2016;21:15-8. doi: 10.1016/j.legalmed.2016.05.005. [PubMed: 27497328].
  • 41. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet. 2008;40(7):827-34. doi: 10.1038/ng.171. [PubMed: 18583979].
  • 42. Lai TJ, Wu CY, Tsai HW, Lin YMJ, Sun HS. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan. BMC med genet. 2005;6(1):14. doi: 10.1186/1471-2350-6-14.
  • 43. Sun HS, Tsai HW, Ko HC, Chang FM, Yeh TL. Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women. Genes Brain Behav. 2004;3(6):328-36. doi: 10.1111/j.1601-183X.2004.00085.x. [PubMed: 15544576].
  • 44. Pawlak J, Dmitrzak-Węglarz M, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Czerski P, et al. Association between suicidal behavior and genes of serotonergic system confirmed in men with affective disorders. J Med Sci. 2014;83(1):7-16.
  • 45. Chen D, Liu F, Yang C, Liang X, Shang Q, He W, et al. Association between the TPH1 A218C polymorphism and risk of mood disorders and alcohol dependence: Evidence from the current studies. J Affect Disord. 2012;138(1-2):27-33. doi: 10.1016/j.jad.2011.04.018. [PubMed: 21601290].
  • 46. Jokela M, Raikkonen K, Lehtimaki T, Rontu R, Keltikangas-Jarvinen L. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord. 2007;100(1-3):191-7. doi: 10.1016/j.jad.2006.10.016. [PubMed: 17134762].
  • 47. Anghelescu I, Klawe C, Fehr C, Singer P, Schleicher A, Himmerich H, et al. The TPH intron 7 A218C polymorphism and TCI dimension scores in alcohol-dependent patients: Hints to nonspecific psychopathology. Addict Behav. 2005;30(6):1135-43. doi: 10.1016/j.addbeh.2004.11.002. [PubMed: 15925123].
  • 48. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, et al. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(2):126-9. doi: 10.1002/ajmg.b.30260. [PubMed: 16389593].
  • 49. Zaboli G, Gizatullin R, Nilsonne A, Wilczek A, Jonsson EG, Ahnemark E, et al. Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology. 2006;31(9):1982-90. doi: 10.1038/sj.npp.1301046. [PubMed: 16495936].
  • 50. Buttenschon HN, Flint TJ, Foldager L, Qin P, Christoffersen S, Hansen NF, et al. An association study of suicide and candidate genes in the serotonergic system. J Affect Disord. 2013;148(2-3):291-8. doi: 10.1016/j.jad.2012.12.011. [PubMed: 23313272].
  • 51. Cichon S, Winge I, Mattheisen M, Georgi A, Karpushova A, Freudenberg J, et al. Brain-specific tryptophan hydroxylase 2 (TPH2): A functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder. Hum Mol Genet. 2008;17(1):87-97. doi: 10.1093/hmg/ddm286. [PubMed: 17905754].
  • 52. Zill P, Baghai TC, Zwanzger P, Schule C, Eser D, Rupprecht R, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry. 2004;9(11):1030-6. doi: 10.1038/ [PubMed: 15124006].
  • 53. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005;45(1):11-6. doi: 10.1016/j.neuron.2004.12.014. [PubMed: 15629698].
  • 54. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry. 2005;62(10):1109-18. doi: 10.1001/archpsyc.62.10.1109. [PubMed: 16203956].
  • 55. Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R, et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry. 2006;63(10):1103-10. doi: 10.1001/archpsyc.63.10.1103. [PubMed: 17015812].
  • 56. Harvey M, Gagne B, Labbe M, Barden N. Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees. Psychiatr Genet. 2007;17(1):17-22. doi: 10.1097/YPG.0b013e3280111877. [PubMed: 17167340].
  • 57. Lopez VA, Detera-Wadleigh S, Cardona I, Kassem L, McMahon FJ. Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry. 2007;61(2):181-6. doi: 10.1016/j.biopsych.2006.03.028. [PubMed: 16806105].
  • 58. Park TW, Park YH, Kwon HJ, Lim MH. Association between TPH2 gene polymorphisms and attention deficit hyperactivity disorder in Korean children. Genet Test Mol Biomarkers. 2013;17(4):301-6. doi: 10.1089/gtmb.2012.0376. [PubMed: 23461725].
  • 59. Coon H, Dunn D, Lainhart J, Miller J, Hamil C, Battaglia A, et al. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet. 2005;135B(1):42-6. doi: 10.1002/ajmg.b.30168. [PubMed: 15768392].
  • 60. Zhang C, Li Z, Shao Y, Xie B, Du Y, Fang Y, et al. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci. 2011;43(3):406-11. doi: 10.1007/s12031-010-9458-2. [PubMed: 20938755].
  • 61. Chen GL, Vallender EJ, Miller GM. Functional characterization of the human TPH2 5' regulatory region: Untranslated region and polymorphisms modulate gene expression in vitro. Hum Genet. 2008;122(6):645-57. doi: 10.1007/s00439-007-0443-y. [PubMed: 17972101]. [PubMed Central: PMC2734478].
  • 62. Rocha FF, Alvarenga NB, Lage NV, Romano-Silva MA, Marco LA, Correa H. Associations between polymorphic variants of the tryptophan hydroxylase 2 gene and obsessive-compulsive disorder. Braz J Psychiatry. 2011;33(2):176-80. [PubMed: 21829912].
  • 63. Baehne CG, Ehlis AC, Plichta MM, Conzelmann A, Pauli P, Jacob C, et al. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol Psychiatry. 2009;14(11):1032-9. doi: 10.1038/mp.2008.39. [PubMed: 18427560].
  • 64. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry. 2005;10(12):1126-32. doi: 10.1038/ [PubMed: 16116490].
  • 65. Zhang X, Beaulieu JM, Gainetdinov RR, Caron MG. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cell Mol Life Sci. 2006;63(1):6-11. doi: 10.1007/s00018-005-5417-4. [PubMed: 16378243]. [PubMed Central: PMC2792355].
  • 66. Hsu CD, Tzang RF, Liou YJ, Hong CJ, Tsai SJ. Family-based association study of tryptophan hydroxylase 2 and serotonin 1A receptor genes in attention deficit hyperactivity disorder. Psychiatr Genet. 2013;23(1):38. doi: 10.1097/YPG.0b013e3283586378. [PubMed: 23247084].
  • 67. Mouri K, Hishimoto A, Fukutake M, Shiroiwa K, Asano M, Nagasaki Y, et al. TPH2 is not a susceptibility gene for suicide in Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1546-50. doi: 10.1016/j.pnpbp.2009.09.002. [PubMed: 19748542].
  • 68. Serretti A, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, et al. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Psychiatry Res. 2011;189(1):26-32. doi: 10.1016/j.psychres.2011.02.001. [PubMed: 21396719].
  • 69. De Luca V, Mueller DJ, Tharmalingam S, King N, Kennedy JL. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol Psychiatry. 2004;9(10):896-7. doi: 10.1038/ [PubMed: 15197398].
  • 70. Gao J, Pan Z, Jiao Z, Li F, Zhao G, Wei Q, et al. TPH2 gene polymorphisms and major depression-a meta-analysis. PLoS One. 2012;7(5). e36721. doi: 10.1371/journal.pone.0036721. [PubMed: 22693556]. [PubMed Central: PMC3365065].
  • 71. Yoon HK, Kim YK. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(3):403-9. doi: 10.1016/j.pnpbp.2008.12.013. [PubMed: 19162119].
  • 72. Serretti A, Mandelli L. The genetics of bipolar disorder: Genome 'hot regions,' genes, new potential candidates and future directions. Mol Psychiatry. 2008;13(8):742-71. doi: 10.1038/mp.2008.29. [PubMed: 18332878].
  • 73. Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009;164(1):331-43. doi: 10.1016/j.neuroscience.2009.03.080. [PubMed: 19358880]. [PubMed Central: PMC3637882].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments